FARN (FARN) News
Track canonical SquawkNews coverage tagged to FARN, FARN. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
FARN: Bexmarilimab leads HR MDS innovation, backed by strong funding and advancing pivotal trials
FARN: Bexmarilimab leads HR MDS innovation, backed by strong funding and advancing pivotal trials
EQUITY | Aug 26, 2026, 02:01 PM UTC
M
FARN: Bexmarilimab reports 45% CR in HR-MDS
FARN says its Bexmarilimab delivered 45% CR in HR-MDS and that EUR 40M raised secures funding through 2027 milestones.
EQUITY | Aug 26, 2026, 01:21 PM UTC
M
FARN: Bexmarilimab reports 45% remission in high-risk MDS
FARN said its bexmarilimab achieved 45% remission in high-risk MDS, and that funding has been secured for pivotal trials.
EQUITY | Aug 26, 2026, 12:57 PM UTC
L
FARON FARN - Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
FARON FARN - Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
EQUITY | Aug 19, 2026, 06:25 AM UTC